JFRDX
Price
$60.31
Change
+$0.59 (+0.99%)
Updated
Sep 15 closing price
Net Assets
23.61B
VIGRX
Price
$245.10
Change
+$2.33 (+0.96%)
Updated
Sep 15 closing price
Net Assets
328.49B
Interact to see
Advertisement

JFRDX vs VIGRX

Header iconJFRDX vs VIGRX Comparison
Open Charts JFRDX vs VIGRXBanner chart's image
Janus Henderson Forty D
Price$60.31
Change+$0.59 (+0.99%)
VolumeN/A
Net Assets23.61B
Vanguard Growth Index Investor
Price$245.10
Change+$2.33 (+0.96%)
VolumeN/A
Net Assets328.49B
JFRDX vs VIGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JFRDX vs. VIGRX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFRDX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 328B vs. JFRDX (23.6B). VIGRX pays higher dividends than JFRDX: VIGRX (0.32) vs JFRDX (0.10). JFRDX was incepted earlier than VIGRX: JFRDX (9 years) vs VIGRX (33 years). JFRDX (0.63) is less costly to investors than VIGRX (0.17). JFRDX is a more actively managed with annual turnover of: 36.00 vs. VIGRX (11.00). JFRDX has a lower initial minimum investment than VIGRX: JFRDX (2500) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 25.56 vs. JFRDX (11.31). VIGRX return over 5 years is better than : 108.68 vs. JFRDX (34.70).
JFRDXVIGRXJFRDX / VIGRX
Total Expense Ratio0.630.17371%
Annual Report Gross Expense Ratio0.630.17371%
Fund Existence9 years33 years-
Gain YTD17.53614.899118%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets23.6B328B7%
Annual Yield % from dividends0.100.3232%
Returns for 1 year11.3125.5644%
Returns for 3 years66.62102.9165%
Returns for 5 years34.70108.6832%
Returns for 10 yearsN/A357.07-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDL2.220.02
+0.91%
Dingdong (Cayman) Limited
IMDX3.090.01
+0.32%
Insight Molecular Diagnostics Inc
FN359.001.00
+0.28%
Fabrinet
BUSE24.44-0.17
-0.69%
First Busey Corp
TCRT2.25-0.06
-2.60%
Alaunos Therapeutics Inc.